| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |